CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS
Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...
Saved in:
Main Authors: | E. A. Pyadushkina (Author), M. Yu. Frolov (Author), M. V. Avksentyeva (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2016-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults
by: E. A. Pyadushkina, et al.
Published: (2018) -
Idiopathic thrombocytopenic purpura
by: L Kayal, et al.
Published: (2014) -
Hyperheptaploidy in idiopathic thrombocytopenic purpura
by: Mohit Chowdhry, et al.
Published: (2018) -
Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022) -
Idiopathic thrombocytopenic purpura masquerading paediatric SLE
by: Meenu Barara, et al.
Published: (2015)